Associate Director, Global Trial Lead - Alzheimer Disease at Bristol-Myers Squibb

Warsaw, Masovian Voivodeship, Poland

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, Clinical ResearchIndustries

Requirements

Bachelor’s degree (BA/BS) or equivalent in a relevant field
Therapeutic Area Experience in Alzheimer Disease preferred
Minimum 7 years’ experience in clinical operations and project management, including multi-national trial leadership
Proven track record of leading complex global clinical trials and teams
Strong communication in English, critical thinking, and stakeholder engagement skills
Up to 25% travel may be required

Responsibilities

Lead and oversee multiple clinical trials from start-up to close-out
Develop and manage project plans, budgets, and resources
Ensure regulatory compliance and maintain high-quality data
Proactively identify and resolve risks to keep trials on track
Lead multi-functional teams and vendors to deliver clinical trials on time, within budget, and at the highest quality standards
Shape study-level strategies and ensure alignment across global teams, managing risks and driving solutions for operational challenges
Build strong partnerships with internal stakeholders and external collaborators to optimize study outcomes
Mentor team members, support organizational initiatives, and contribute to a culture of excellence
Foster an inclusive, collaborative, and high-performing team environment

Skills

Clinical Trials

Global Trial Management

Alzheimer Disease

Therapeutic Area Expertise

Risk Management

Study Strategy

Vendor Management

Cross-Functional Leadership

Stakeholder Collaboration

Team Mentoring

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free